Tamarack Advisers, LP Nektar Therapeutics Transaction History

Tamarack Advisers, LP

  • $2.12 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 08, 2018
SELL
$57.4 - $108.44 $6.03 Million - $11.4 Million
-105,000 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$23.02 - $60.5 $10.2 Million - $26.9 Million
-445,000 Reduced 80.91%
105,000 $6.27 Million
Q3 2017

Nov 13, 2017
BUY
$17.79 - $24.0 $9.78 Million - $13.2 Million
550,000
550,000 $13.2 Million

Others Institutions Holding NKTR

# of Institutions
146
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $197M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Tamarack Advisers, LP Portfolio

Follow Tamarack Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Tamarack Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email